AR099557A1 - Fgf-18 en trasplantes de injertos y procedimientos de ingeniería de tejido - Google Patents

Fgf-18 en trasplantes de injertos y procedimientos de ingeniería de tejido

Info

Publication number
AR099557A1
AR099557A1 ARP150100506A ARP150100506A AR099557A1 AR 099557 A1 AR099557 A1 AR 099557A1 AR P150100506 A ARP150100506 A AR P150100506A AR P150100506 A ARP150100506 A AR P150100506A AR 099557 A1 AR099557 A1 AR 099557A1
Authority
AR
Argentina
Prior art keywords
cartilage
fgf
procedures
culture
transfers
Prior art date
Application number
ARP150100506A
Other languages
English (en)
Inventor
Gigout Anne
Guehring Hans
H Ladel Christoph
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR099557A1 publication Critical patent/AR099557A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3612—Cartilage, synovial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/3654—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)

Abstract

La presente solicitud proporciona métodos relacionados con la medicina regenerativa para el tratamiento de los trastornos del cartílago y el daño al cartílago en particular. Más particularmente se refiere a un compuesto FGF-18 para utilizar en la ingeniería del tejido y en los procedimientos de injertos, tales como el trasplante osteocondral o del cartílago o el implante de condrocito análogo (ACI). Reivindicación 1: Un proceso para producir un material de cartílago trasplantable para la ingeniería de tejidos, en el que dicho procedimiento comprende las etapas de cultivar células condrogénicas, ya sea en cultivo en monocapa o en un cultivo en 3D, en un medio de cultivo que contiene un compuesto FGF-18 durante un tiempo suficiente para permitir la formación de un material de cartílago trasplantable.
ARP150100506A 2014-02-20 2015-02-20 Fgf-18 en trasplantes de injertos y procedimientos de ingeniería de tejido AR099557A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14000599 2014-02-20

Publications (1)

Publication Number Publication Date
AR099557A1 true AR099557A1 (es) 2016-08-03

Family

ID=50151087

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100506A AR099557A1 (es) 2014-02-20 2015-02-20 Fgf-18 en trasplantes de injertos y procedimientos de ingeniería de tejido

Country Status (17)

Country Link
US (2) US20170056554A1 (es)
EP (1) EP3107591B1 (es)
JP (1) JP6495934B2 (es)
KR (1) KR102437057B1 (es)
CN (1) CN106232153B (es)
AR (1) AR099557A1 (es)
AU (1) AU2015220781B2 (es)
BR (1) BR112016018704B1 (es)
CA (1) CA2938795A1 (es)
ES (1) ES2676318T3 (es)
IL (1) IL247105B (es)
MX (1) MX2016010873A (es)
NZ (1) NZ723169A (es)
RU (1) RU2682159C2 (es)
SG (1) SG11201606696UA (es)
WO (1) WO2015124735A1 (es)
ZA (1) ZA201605549B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6431082B2 (ja) 2014-02-20 2018-11-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Ｆｇｆ−１８化合物の投与計画
AR099556A1 (es) 2014-02-20 2016-08-03 Merck Patent Gmbh Implante que contiene fgf-18
CN107058217A (zh) * 2017-01-22 2017-08-18 广州赛莱拉干细胞科技股份有限公司 一种软骨细胞的增殖培养基及增殖培养方法
US20200128812A1 (en) * 2017-03-17 2020-04-30 Merck Patent Gmbh Cartilage preservation media
CN113244413B (zh) * 2021-06-28 2021-10-26 深圳市瑞吉生物科技有限公司 一种mRNA剂型的骨关节炎药物制剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511958B1 (en) * 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
US20140193468A1 (en) * 2001-03-23 2014-07-10 Histogenics Corporation Methods for preparation of neo-cartilage constructs
WO2004032849A2 (en) * 2002-10-07 2004-04-22 Zymogenetics, Inc. Methods of administering fgf18
UA99818C2 (ru) * 2006-08-25 2012-10-10 Эйрэс Трейдинг С.А. Лечение заболеваний хряща
WO2008023063A2 (en) * 2006-08-25 2008-02-28 Ares Trading S.A. Treatment of cartilage disorders with fgf-18
JP5388233B2 (ja) * 2011-01-19 2014-01-15 富士ソフト株式会社 再生軟骨の軟骨特性を評価する方法

Also Published As

Publication number Publication date
BR112016018704A2 (pt) 2017-10-17
KR20160124149A (ko) 2016-10-26
KR102437057B1 (ko) 2022-08-26
WO2015124735A1 (en) 2015-08-27
AU2015220781B2 (en) 2018-05-24
NZ723169A (en) 2023-05-26
EP3107591A1 (en) 2016-12-28
CN106232153B (zh) 2020-01-17
US20220378981A1 (en) 2022-12-01
CA2938795A1 (en) 2015-08-27
MX2016010873A (es) 2016-11-17
EP3107591B1 (en) 2018-04-18
BR112016018704B1 (pt) 2021-01-05
IL247105A0 (en) 2016-09-29
RU2682159C2 (ru) 2019-03-15
IL247105B (en) 2020-02-27
CN106232153A (zh) 2016-12-14
AU2015220781A1 (en) 2016-09-01
RU2016137290A3 (es) 2018-09-07
JP2017508523A (ja) 2017-03-30
ZA201605549B (en) 2018-12-19
US20170056554A1 (en) 2017-03-02
ES2676318T3 (es) 2018-07-18
JP6495934B2 (ja) 2019-04-03
SG11201606696UA (en) 2016-09-29
RU2016137290A (ru) 2018-03-23

Similar Documents

Publication Publication Date Title
MX2017004890A (es) Metodos y composiciones para la generación o el mantenimiento de células pluripotentes.
AR099557A1 (es) Fgf-18 en trasplantes de injertos y procedimientos de ingeniería de tejido
SG10201804052UA (en) hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
AR080434A1 (es) Metodo para purificar celulas derivadas de celulas madre pluripotenciales
EP4292600A3 (en) Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
AR082820A1 (es) Diferenciacion de celulas madre embrionarias humanas
PH12018500371A1 (en) Clinical formulations
CR20160528A (es) Compuestos y composiciones para inducir condrogénesis
AR098693A1 (es) Método para producir células del epitelio pigmentario retiniano (rpe)
MX2017008727A (es) Composiciones y metodos para usar un insecticida con bacillus sp. d747.
WO2016081032A3 (en) Mesenchymal stem cells derived from induced pluripotent stem cells
MX2020004811A (es) Métodos y composiciones de reconstrucción no mieloablativa de médula ósea.
MX2019002223A (es) Procedimiento mejorado para el cultivo de algas.
ECSP14013157A (es) Formulaciones liofilizadas de fgf-18
CL2019003595A1 (es) Bacterias probióticas preacondicionadas en un medio que contiene gos y uso de estas.
SG11201804755VA (en) Method for manufacturing tissue/organ by using blood cells
CO2018003988A2 (es) Un método de cultivo de células
CO2019003982A2 (es) Método para preparar un suplemento a partir de cultivos de células mesenquimales de gelatina de wharton y usos del mismo
IN2013CH00932A (es)
MX2016013680A (es) Métodos y composiciones para el tratamiento de trastornos por el almacenamiento de lípidos.
PE20170625A1 (es) Procedimiento para generacion de gemelos homocigoticos por biparticion embrionaria
EA202090133A1 (ru) Способ получения трансплантируемой хрящевой ткани
SA117390093B1 (ar) طريقة لإنتاج بناءات نانو سليلوز
PH12017500154A1 (en) Method for preparing induced pluripotent stem cell line from mesenchymal stem cells, and cell line obtained thereby
RU2014146669A (ru) Создание трехмерных структур смешанных популяций клеток человека для использования в регенеративной медицине